(Q53329714)

13 May 2018

title

Serum fatty-acid composition and the risk of Alzheimer's disease: a longitudinal population-based study. (English)

1 reference

13 May 2018

0 references

1 reference

fatty acid composition

1 reference

E Rönnemaa

1

1 reference

13 May 2018

B Zethelius

2

1 reference

13 May 2018

B Vessby

3

1 reference

13 May 2018

L Lannfelt

4

1 reference

13 May 2018

L Byberg

5

1 reference

13 May 2018

L Kilander

6

1 reference

13 May 2018

publication date

20 June 2012

1 reference

13 May 2018

European Journal of Clinical Nutrition

published in

1 reference

13 May 2018

volume

66

1 reference

13 May 2018

issue

8

1 reference

13 May 2018

page(s)

885-890

1 reference

13 May 2018

Dietary n-6 PUFA deprivation downregulates arachidonate but upregulates docosahexaenoate metabolizing enzymes in rat brain

cites work

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.63

Food combination and Alzheimer disease risk: a protective diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.63

Differences in the fatty acid composition of the grey and white matter of different regions of the brains of patients with Alzheimer's disease and control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.63

Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.63

Uses and limitations of statistical accounting for random error correlations, in the validation of dietary questionnaire assessments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.63

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.63

Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.63

Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.63

Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.63

Omega-3 fatty acids and risk of dementia: the Canadian Study of Health and Aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.63

Item response theory facilitated cocalibrating cognitive tests and reduced bias in estimated rates of decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.63

Omega-3 fatty acids, cognitive decline, and Alzheimer's disease: a critical review and evaluation of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.63

Omega-3 fatty acids and dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.63

Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.63

Dietary fats, cerebrovasculature integrity and Alzheimer's disease risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.63

The cell biology of Alzheimer's disease: uncovering the secrets of secretases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.63

Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.63

Benefits of fatty fish on dementia risk are stronger for those without APOE epsilon4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.63

Biomarkers and the measurement of fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.63

Role of liver and plasma lipoproteins in selective transport of n-3 fatty acids to tissues: a comparative study of 14C-DHA and 3H-oleic acid tracers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.63

Metabolic risk factors for stroke and transient ischemic attacks in middle-aged men: a community-based study with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.63

Multiple imputation for estimating the risk of developing dementia and its impact on survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.63

De novo lipogenesis in humans: metabolic and regulatory aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.63

Plasma n-3 fatty acids and the risk of cognitive decline in older adults: the Atherosclerosis Risk in Communities Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.63

7 January 2021

n 3 fatty acid proportions in plasma and cognitive performance in older adults.

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.63

7 January 2021

Markers of dietary fat quality and fatty acid desaturation as predictors of total and cardiovascular mortality: a population-based prospective study

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.63

7 January 2021

The serum cholesterol ester fatty acid composition but not the serum concentration of alpha tocopherol predicts the development of myocardial infarction in 50-year-old men: 19 years follow-up

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.63

7 January 2021

Platelet fatty acid composition in relation to fatty acid composition in plasma and to serum lipoprotein lipids in healthy subjects with special reference to the linoleic acid pathway

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.63

7 January 2021

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop.

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.63

7 January 2021

Low plasma eicosapentaenoic acid and depressive symptomatology are independent predictors of dementia risk

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.63

7 January 2021

Cognitive decline and fatty acid composition of erythrocyte membranes--The EVA Study

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.63

7 January 2021

n-3 Fatty acid erythrocyte membrane content, APOE varepsilon4, and cognitive variation: an observational follow-up study in late adulthood

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.63

7 January 2021

Alzheimer's disease and smoking: bias in cohort studies.

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.63

7 January 2021

Identifiers

DOI

10.1038/EJCN.2012.63

1 reference

13 May 2018

Dimensions Publication ID

1042708297

0 references

1 reference

13 May 2018